We develop functional high-performance materials based on poly(2-oxazoline)s (POx): precise, scalable and biocompatible. Our focus is on manufacturing and applying next-generation solubilizers for active ingredients, cosmetic actives and other demanding formulations. POx are versatile materials: they solubilize, stabilize, protect and enable controlled release. Their modular chemistry allows us to design custom-tailored solutions for real formulation challenges, often with superior precision and performance compared to conventional alternatives. Our technology is built on a patented synthesis platform that enables us to produce POx in defined structure, high purity and scalable quantities. This makes a powerful class of materials accessible for industrial use – materials that have long been established in academic research but were rarely available commercially. Oxaphil combines deep scientific expertise with a clear application focus. Our team brings together backgrounds in polymer chemistry, formulation science and technology transfer. In collaboration with partners, we translate POx from the lab to real-world applications from cosmetics to biotechnology and pharmaceuticals.
| Website | https://oxaphil.com |
| Employees | 3 (2 on RocketReach) |
| Founded | 2025 |
| Industry | Chemical Manufacturing |
Looking for a particular Oxaphil employee's phone or email?
2 people are employed at Oxaphil.
Oxaphil is based in Dresden, Saxony.